TACR1 and obesity disorder: In mice with diet-induced obesity, Ramalho and collaborators showed that treatment with an antagonist of substance P-receptor (NK1-R) resulted in lower body weight gain, reduced food intake, smaller adipocytes, and lower glycaemia and insulinemia compared to the placebo group [67].